MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Rethinking Strategies for Construction Success
Encouraging project team stakeholders to communicate, collaborate, care and align around a common goal.
From Touchless to Total Performance: Healthcare Restroom Design Redefined
Facility managers are raising the bar on hygiene, durability and system performance by turning restrooms into frontline assets for infection prevention and patient confidence.
New York State Approves $53M Construction Program at Niagara Falls Memorial Medical Center
DOH greenlights first $6.5M phase, launching campus-wide upgrades to clinical spaces, infrastructure and patient care services through 2027.
How Health Systems Are Rethinking Facilities Amid Margin Pressure
As insurance uncertainty and consolidation reshape healthcare, facilities managers are turning to efficiency, adaptability and portfolio optimization to control costs.
Ground Broken on New Medical Office Building in Scottsdale, AZ
Hammes is developing a new 34,000-square-foot medical office building in Scottsdale, Arizona, in partnership with Phoenix-based NOVO Development.